Coronavirus Imprimare
Sanatate
Vineri, 28 Februarie 2020 19:59

                          

 

OMS a declarat o urgență globală pentru sănătate în legătură cu răspândirea virusului Covid-19.

 

Coronavirus disease 2019 (COVID-19)Situation Report –38

Nine new Member States (Brazil, Denmark, Estonia, Georgia, Greece, Norway, Pakistan, Romania, and NorthMacedonia) reported cases of COVID-19 in the past 24 hours. •WHO and the World Tourism Organization released a joint statement regarding responsibility and coordination on tourism and COVID-19. For more information, please visit this webpage.•OpenWHO, aweb-based learning platform, has launched the free online courses Introduction to Emerging Respiratory Viruses, Including Novel Coronovirus, in Portugueseand Health and Safety Briefing for Respiratory Diseases –ePROTECT in Frenchtoday. •WHO is utilizing an international network of expert laboratories to provide support in the detection of the COVID-19 virus globally.For more information, please see the Subject in Focus below
SITUATION IN NUMBERS total and new cases in last 24 hours
Globally 82 294confirmed (1185new)
China78 630confirmed (439new)2747deaths (29new)
Outside of China3664confirmed (746new)46 countries (9 new)57 deaths (13 new)WHO RISK ASSESSMENT
China        Very High
Regional   LevelHigh
Global      LevelHigh

 

 

 

  

SITUATION IN FOCUS: Laboratory Network and DetectionOn 9 January 2020, WHO published interim laboratoryguidance for detection of the novel coronavirus. This guidance is continually updated as more data becomes available and includes advice on sample collection, diagnostic testing, and pathogen characterization. Specific interim guidance on biosafety in the laboratoryhas also been published. An update tothe guidance for the international shipment of specimens will follow soon. WHO is utilizing an international network of expert laboratoriesto provide support in the detection of the COVID-19 virus globally

The diagnostic landscape of this outbreak is changing quickly. The first COVID-19 cases were detected using genomic sequencing, but multiple RT-PCR commercial and non-commercial assays have since been developed. As the international case load increases, there is an urgent need to rapidly scale up diagnostic capacity to detect and confirm casesof COVID-19. WHO has taken a three-pronged approach to enhance global diagnostic capacity for the COVID-19 virus: 1)Developing a WHO network of 15 COVID-19 reference laboratories with demonstrated expertise in the molecular detection of coronaviruses. These international laboratories can support national labs to confirm the COVID-19 virus and troubleshoot their molecular assays.2)Strengthening national capacity for detection of the COVID-19 virus so that diagnostic testing can be performed rapidly without the need for overseas shipping. Existing global networks for detection of respiratory pathogens are being utilized including, notably, the National Influenza Centers that support the Global Influenza Surveillance and Response System.3)Ensuring ongoing test availability. WHO has procured a commercial assay (manufactured under ISO:13485)with strong performance data and shipped to over 150 laboratories globally as an interim measure for Member States requesting support. The main goal is to strengthen global diagnostic capacity for detection of the COVID-19 virus. Support is now also provided to ensure the quality of testing through the implementation of an External Quality Assurance mechanism.Public health efforts are targeted at both interruptingfurther transmission and monitoring the spreadof COVID-19. As reports of asymptomatic cases increase, the need forreliable serology testing is becoming more urgent. There are a number of groups working on this and developments are being monitored.

 

 

*